Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Prostaglandin E2 receptor 3 (EP3) is a G protein-coupled receptor (GPCR) that binds prostaglandin E2 (PGE2), a lipid mediator involved in various physiological and pathological processes. Activation of EP3 leads to diverse effects depending on the tissue context, impacting metabolism, pain modulation, cardiovascular function, and gastrointestinal protection. EP3 is considered a therapeutic target for diseases like obesity, diabetes, inflammatory pain, and heart failure.
Gi protein-mediated inhibition of adenylate cyclase/cAMP; some increase Ca²⁺
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E2 Receptor 3 (EP3).